Martin R. Farlow, is Professor Emeritus in the Department of Neurology at Indiana University and co-director of the Alzheimer’s Disease Center at Indiana University.

Dr. Farlow is one of the country’s leaders in Alzheimer disease (AD) and other cognitive disorders.  An expert clinical trialist, Dr. Farlow has conducted over 150 clinical studies of new drug candidates for the treatment of AD and related dementias.

Dr Farlow also has clinically characterized and helped determine genetic linkage for several familial dementias including the second mutation associated with autosomal dominantly inherited Alzheimer’s disease, Gerstmann-Straussler-Scheinker disease, and Multi Systems Tauopathy with Dementia

He has lectured on the topics of aging, dementia, and AD at more than 300 meetings, conferences, and hospitals/medical schools throughout the world.  A prolific author, Dr. Farlow has presented more than 467 abstracts at professional meetings and has authored or co-authored more than 455 articles published in peer-reviewed journals.

Dr. Farlow is a member of many professional associations including the American Academy of Neurology and the American Neurological Association. He is also a founding member of both the American Society of Experimental Neurotherapeutics and the International Society for CNS Clinical Trials and Methodology

Dr. Farlow received his medical degree from Indiana University School of Medicine.  He completed an internship in Internal Medicine and a residency in neurology at the Indiana University Hospitals.